1. Home
  2. SNX vs VTRS Comparison

SNX vs VTRS Comparison

Compare SNX & VTRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNX
  • VTRS
  • Stock Information
  • Founded
  • SNX 1980
  • VTRS 1961
  • Country
  • SNX United States
  • VTRS United States
  • Employees
  • SNX N/A
  • VTRS N/A
  • Industry
  • SNX Retail: Computer Software & Peripheral Equipment
  • VTRS Medicinal Chemicals and Botanical Products
  • Sector
  • SNX Technology
  • VTRS Health Care
  • Exchange
  • SNX Nasdaq
  • VTRS Nasdaq
  • Market Cap
  • SNX 11.7B
  • VTRS 11.8B
  • IPO Year
  • SNX 2003
  • VTRS N/A
  • Fundamental
  • Price
  • SNX $149.88
  • VTRS $10.65
  • Analyst Decision
  • SNX Strong Buy
  • VTRS Hold
  • Analyst Count
  • SNX 10
  • VTRS 5
  • Target Price
  • SNX $149.80
  • VTRS $10.40
  • AVG Volume (30 Days)
  • SNX 536.4K
  • VTRS 9.6M
  • Earning Date
  • SNX 09-25-2025
  • VTRS 08-07-2025
  • Dividend Yield
  • SNX 1.22%
  • VTRS 4.49%
  • EPS Growth
  • SNX 19.95
  • VTRS N/A
  • EPS
  • SNX 8.55
  • VTRS N/A
  • Revenue
  • SNX $60,007,297,000.00
  • VTRS $14,115,700,000.00
  • Revenue This Year
  • SNX $4.71
  • VTRS N/A
  • Revenue Next Year
  • SNX $4.14
  • VTRS $1.85
  • P/E Ratio
  • SNX $17.51
  • VTRS N/A
  • Revenue Growth
  • SNX 6.60
  • VTRS N/A
  • 52 Week Low
  • SNX $92.23
  • VTRS $6.85
  • 52 Week High
  • SNX $153.70
  • VTRS $13.55
  • Technical
  • Relative Strength Index (RSI)
  • SNX 59.90
  • VTRS 71.38
  • Support Level
  • SNX $143.09
  • VTRS $10.55
  • Resistance Level
  • SNX $153.70
  • VTRS $10.82
  • Average True Range (ATR)
  • SNX 3.11
  • VTRS 0.31
  • MACD
  • SNX -0.41
  • VTRS 0.09
  • Stochastic Oscillator
  • SNX 73.57
  • VTRS 91.83

About SNX TD SYNNEX Corporation

TD Synnex Corp is a distributor and solutions aggregator for the IT ecosystem. The company aggregates and distributes IT hardware, software, and systems including personal computing devices and peripherals, mobile phones and accessories, printers, server and data center infrastructure, hybrid cloud, security, networking, communications and storage solutions, and system components. Its geographical segments include the Americas, Europe, and APJ.

About VTRS Viatris Inc.

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. The remaining 60% of sales are derived from its portfolio of legacy products, which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.

Share on Social Networks: